Rchr
J-GLOBAL ID:201801003604443714   Update date: May. 22, 2024

Yu Nishida

ニシダ ユウ | Yu Nishida
Affiliation and department:
Research field  (1): Gastroenterology
Research keywords  (3): inflammatory bowel disease ,  Crohn's disease ,  ulcerative colitis
Research theme for competitive and other funds  (2):
  • 2019 - 2022 腸管粘膜傷害におけるプロスタグランジン輸送タンパク(SLCO2A1)の役割の検討
  • 2017 - 2019 腸管上皮恒常性維持におけるSLCO2A1遺伝子変異とPGE2分泌能変化の影響
Papers (36):
  • Shuhei Hosomi, Yu Nishida, Yasuhiro Fujiwara. Efficacy of Upadacitinib as a Second-line JAK Inhibitor in Ulcerative Colitis: A Case Series. Internal medicine (Tokyo, Japan). 2023
  • Yasuhiro Fujiwara, Akinari Sawada, Akira Higashimori, Rieko Nakata, Kojiro Tanoue, Yu Nishida, Hirotsugu Maruyama, Masaki Ominami, Shusei Fukunaga, Koji Otani, et al. The impact of COVID-19 on Japanese patients with eosinophilic gastrointestinal disorders during the vaccination era. JGH open : an open access journal of gastroenterology and hepatology. 2023. 7. 10. 702-707
  • Yu Nishida, Shuhei Hosomi, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Yasuaki Nagami, et al. Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review. Healthcare (Basel, Switzerland). 2023. 11. 19
  • Hiroaki Okuda, Shuhei Hosomi, Shigehiro Itani, Noriyuki Kurimoto, Yumie Kobayashi, Rieko Nakata, Yu Nishida, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, et al. Pretreatment serum monocyte chemoattractant protein-1 as a predictor of long-term outcome by ustekinumab in patients with Crohn's disease. Journal of gastroenterology and hepatology. 2023. 38. 6. 910-920
  • Noriyuki Kurimoto, Yu Nishida, Shuhei Hosomi, Shigehiro Itani, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, et al. Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing. PloS one. 2023. 18. 1. e0280252
more...
MISC (7):
more...
Lectures and oral presentations  (6):
  • 潰瘍性大腸炎患者におけるタクロリムス療法後の免疫調整剤による寛解維持効果の検討
    (第60回日本消化器病学会大会 2018)
  • Thioprines are essential following oral tacrolimus induction therapy for patients with ulcerative colitis
    (Asian organization for crohn's and colitis 2018)
  • 潰瘍性大腸炎に対するインフリキシマブの有効性と効果予測因子の検討
    (第104回日本消化器病学会総会 2018)
  • Serum interleukin-6 predicts future outcomes of infliximab for ulcerative colitis
    (13th congress of european crohn's and colitis organization (ECCO) 2018)
  • Serum interleukin-6 level predicts short-term clinical response of anti-tumor nercrosis factor therapy in patients with ulcerative colitis
    (AGA 2017 2017)
more...
Education (2):
  • 2013 - 2017 Osaka City University
  • 2001 - 2007 Nara Medical University Medical Faculty Medical Department
Professional career (1):
  • 医学博士 (大阪市立大学)
Work history (6):
  • 2019/10 - 現在 大阪市立大学医学部 消化器内科 病院講師
  • 2017/04 - 現在 大阪市立大学医学部付属病院 後期研究医
  • 2012/04 - 2014/03 医療法人寺西報恩会長吉総合病院
  • 2011/04 - 2012/03 大阪市立大学医学部付属病院 前期研究医
  • 2009/04 - 2011/03 医療法人橘会東住吉森本病院
Show all
Association Membership(s) (3):
JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page